- call +1-201-465-4211
- email sales@mrinsights.biz
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
Scope of the Report:
This report studies the Anticoagulation Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anticoagulation Therapy market by product type and applications/end industries.
Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC’s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.
North America accounted for the largest market share of anticoagulation therapy market owing to rising number of the hospital associated clinics and high healthcare expenditure. Europe is expected to grow at the higher rate and generate quite the substantial amount of revenue owing to rising incidence of venous thromboembolism, atrial fibrillation, and stroke. On the other hand, APAC is the fastest growing region, registering the CAGR of 8.1% over the forecast period due to long-term administration and high volume of recurring sales of anticoagulation drugs for long lasting medical aid therapy.
The global Anticoagulation Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anticoagulation Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson＆Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Alere
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NOACs
Warfarin
Market Segment by Applications, can be divided into
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Anticoagulation Therapy Market Overview
1.1 Product Overview and Scope of Anticoagulation Therapy
1.2 Classification of Anticoagulation Therapy by Types
1.2.1 Global Anticoagulation Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Anticoagulation Therapy Revenue Market Share by Types in 2017
1.2.3 NOACs
1.2.4 Warfarin
1.3 Global Anticoagulation Therapy Market by Application
1.3.1 Global Anticoagulation Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Associated Clinics
1.3.3 Independent Clinics
1.3.4 Pharmacy-Based Clinics
1.4 Global Anticoagulation Therapy Market by Regions
1.4.1 Global Anticoagulation Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Anticoagulation Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anticoagulation Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anticoagulation Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Anticoagulation Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anticoagulation Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Anticoagulation Therapy (2013-2023)
2 Manufacturers Profiles
2.1 CH Boehringer Sohn
2.1.1 Business Overview
2.1.2 Anticoagulation Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CH Boehringer Sohn Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Anticoagulation Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson＆Johnson
2.3.1 Business Overview
2.3.2 Anticoagulation Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson＆Johnson Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Anticoagulation Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Daiichi Sankyo
2.5.1 Business Overview
2.5.2 Anticoagulation Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Daiichi Sankyo Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Portola Pharmaceuticals
2.6.1 Business Overview
2.6.2 Anticoagulation Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Portola Pharmaceuticals Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Anticoagulation Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Alere
2.8.1 Business Overview
2.8.2 Anticoagulation Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alere Anticoagulation Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anticoagulation Therapy Market Competition, by Players
3.1 Global Anticoagulation Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Anticoagulation Therapy Players Market Share
3.2.2 Top 10 Anticoagulation Therapy Players Market Share
3.3 Market Competition Trend
4 Global Anticoagulation Therapy Market Size by Regions
4.1 Global Anticoagulation Therapy Revenue and Market Share by Regions
4.2 North America Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
5 North America Anticoagulation Therapy Revenue by Countries
5.1 North America Anticoagulation Therapy Revenue by Countries (2013-2018)
5.2 USA Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
6 Europe Anticoagulation Therapy Revenue by Countries
6.1 Europe Anticoagulation Therapy Revenue by Countries (2013-2018)
6.2 Germany Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
6.4 France Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Anticoagulation Therapy Revenue by Countries
7.1 Asia-Pacific Anticoagulation Therapy Revenue by Countries (2013-2018)
7.2 China Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
7.5 India Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
8 South America Anticoagulation Therapy Revenue by Countries
8.1 South America Anticoagulation Therapy Revenue by Countries (2013-2018)
8.2 Brazil Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Anticoagulation Therapy by Countries
9.1 Middle East and Africa Anticoagulation Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Anticoagulation Therapy Revenue and Growth Rate (2013-2018)
10 Global Anticoagulation Therapy Market Segment by Type
10.1 Global Anticoagulation Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Anticoagulation Therapy Market Forecast by Type (2018-2023)
10.3 NOACs Revenue Growth Rate (2013-2023)
10.4 Warfarin Revenue Growth Rate (2013-2023)
11 Global Anticoagulation Therapy Market Segment by Application
11.1 Global Anticoagulation Therapy Revenue Market Share by Application (2013-2018)
11.2 Anticoagulation Therapy Market Forecast by Application (2018-2023)
11.3 Hospital Associated Clinics Revenue Growth (2013-2018)
11.4 Independent Clinics Revenue Growth (2013-2018)
11.5 Pharmacy-Based Clinics Revenue Growth (2013-2018)
12 Global Anticoagulation Therapy Market Size Forecast (2018-2023)
12.1 Global Anticoagulation Therapy Market Size Forecast (2018-2023)
12.2 Global Anticoagulation Therapy Market Forecast by Regions (2018-2023)
12.3 North America Anticoagulation Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Anticoagulation Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Anticoagulation Therapy Revenue Market Forecast (2018-2023)
12.6 South America Anticoagulation Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Anticoagulation Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Anticoagulation Therapy Picture
Table Product Specifications of Anticoagulation Therapy
Table Global Anticoagulation Therapy and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
